Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Current Liabilities ₹5,819 Cr₹4,546 Cr₹4,689 Cr₹4,201 Cr₹4,126 Cr

What is the latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹5,819 Cr based on Mar2024 Consolidated results.
Year Total Current Liabilities
Mar2024₹5,819 Cr
Mar2023₹4,546 Cr
Mar2022₹4,689 Cr
Mar2021₹4,201 Cr
Mar2020₹4,126 Cr

How is Total Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2024 ₹5,819 Cr
27.99
Mar2023 ₹4,546 Cr
-3.05
Mar2022 ₹4,689 Cr
11.63
Mar2021 ₹4,201 Cr
1.82
Mar2020 ₹4,126 Cr -

Compare Total Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,869.1 Cr 0.9% 23% 49.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,466.0 Cr 1.7% 2% -0.6% Stock Analytics
DIVIS LABORATORIES ₹177,298.0 Cr 0.4% -2% 37.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,538.0 Cr 6% 10.5% 13.6% Stock Analytics
CIPLA ₹127,140.0 Cr 6.8% 4.6% -0.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,500.0 Cr 4.2% 1.3% -6.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.9%

23%

49.1%

SENSEX

-1%

-3.2%

1.6%


You may also like the below Video Courses